(PharmaNewsWire.Com, August 30, 2017 ) Antiviral Drugs helps in combating viral infections by hampering the replication of viruses and strengthening the immune response to the viral infection. From the past few years resistance is observed among viruses against different antiviral drugs with increasing diversity of viruses. This challenge leads to the evolution of broad spectrum antiviral drugs that specifically attack viruses at specified targets such as DNA Polymerase, NS3 Protease, & Reverse Transcriptase. These drugs are used to prevent or cure different viral infections such as HIV/AIDS, Hepatitis, influenza, and other viral infections.
The growth of Antiviral Drugs in Middle East & Africa market is majorly driven by factors such as increased public awareness, rise in healthcare expenditure, emergence of life-threatening diseases, and increase in viral infection incidences. The key restraints of the market are high cost involved in drug development, lack of incentivization, use of natural medicines, and limited access to healthcare. The countries with average and low level income such as Africa are highly susceptible to acute and chronic diseases like influenza, HIV/AIDS, and hepatitis due to lack of basic healthcare facilities, high cost of life-saving drugs, and import restriction. Lack of public awareness about chronic and transmissible diseases also makes the region extremely vulnerable. As per World Health Organization, 25.6 million people are living with HIV in Sub-Saharan Africa in 2015, making it one of the most affected region, but high pricing keep the product out of the reach of most people.
Middle East & Africa Antiviral Drugs Market is segmented on the basis of Application, Target, and End-Users. Based on Application, the market is classified into HIV/AIDS, Hepatitis, Herpes, Influenza, and Others. On the basis of Target, the market is classified into DNA polymerase, NS3 Protease, Reverse transcriptase, and Others. On the basis of End-Users, the market is classified into Hospitals, Research Institutes, and Laboratory Centers. Geographically Antiviral drugs market is segmented as Africa and Middle-East regions.
The major companies dominating the Antiviral Drugs Market are Johnson & Johnson (USA), Novartis International AG (Switzerland), Roche Holding AG (Switzerland), Pfizer (USA), Merck and Co. Inc (USA), GlaxoSmithKline plc (United Kingdom), AstraZeneca AB (United Kingdom), Gilead Sciences (USA), and Abbott Laboratories (USA).
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
